B-Cell Lymphoma with Kite Yescarta, Adult

Yescarta, developed by Kite, is a type of immunotherapy for adult patients with B-Cell Lymphoma. Through Yescarta therapy, a patient's T-cells are genetically reprogrammed to fight cancer cells.

3 Result(s)

Distance

Johns Hopkins Hospital

1800 Orleans St.
BALTIMORE, MD 21287

10 Miles

Learn more

UT Southwestern Medical Center

5323 Harry Hines Blvd
DALLAS, TX 75390

1171 Miles

Learn more

Stanford Health Care

300 Pasteur Dr.
PALO ALTO, CA 94305-2200

2434 Miles

Learn more

Details

Inclusions

The Bundled Rate plus Outlier Per Diems includes:

1. Those comprehensive facility services, supplies, and equipment necessary to perform the Bundled Procedure and rendered by PROVIDER 2. Those professional services necessary to perform the Bundled Procedure and rendered by a Physician 3. The treatment of any complication resulting from the performance of the Bundled Procedure 4. The Cost of the CAR T-Cell Product is included in the bundled rate. The Bundled Rate period begins on the day of the prep regime for the scheduled Accarent Procedure and covers up to 25 inpatient days in the hospital. Should the length of stay exceed 25 inpatient days, then per diem outlier payments will be applicable for each subsequent inpatient day. Covered outpatient follow-up services related to the bundled procedure beginning on the day of infusion through 60 calendar days are included in the bundled price.

Exclusions

Any chemotherapy provided / administered between after collection of stem cells and before the preparative regimen.

Candidacy

Candidacy for the bundled procedure will be determined by the Provider.

B-Cell Lymphoma with Kite Yescarta, Adult

Similar Procedures